Yingqi Hua

11PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersNonlinear optics and spectroscopyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 04, 2026
A single-molecule prodrug synergistically suppresses MYC-amplified osteosarcoma through sequential nitric oxide release and photodynamic therapy.

|May 05, 2026
UBA2-High Osteosarcoma Suppresses Immune Infiltration by Autophagy-Mediated MHC-I Degradation.

|Apr 08, 2026
Sibling Osteosarcoma Without Retinoblastoma Associated With a Low Penetrance RB1 Variant: Whole Genome Findings From a Single Family.

Weisong Zhao, Zhuoying Wang, Kai Tian

|Mar 03, 2026
Ginkgetin targets GRP78 to induce dual pathways of ER stress and immune activation in osteosarcoma.

Wenyuan Xu, Tongtong Liu, Xinglong Ma

|Jan 30, 2026
TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness.

Yining Tao, Qi Zhang, Haoyu Wang

|Dec 01, 2025
Clinical Application of an Ultrasonic Bone Scalpel in the Treatment of Osteoid Osteoma: A Single-Center Pilot Study.

He Dong, Jing Han, Binghui Yang

Pageof 2

Frequent Collaborators

5 joint publications

Zhengdong Cai

4 joint publications

Weisong Zhao

3 joint publications

Wei Sun

2 joint publications

Liu Yang